Press Release: Intercept : Intercept Presents New Data on the Results of OCA-Bezafibrate Combination Therapy in PBC After Six Months of Treatment in Late-Breaking Poster Presentation at EASL Congress 2024

Results show combination of OCA 5-10 mg and bezafibrate 400 mg normalizes multiple serum biomarkers that are associated with improved transplant-free and decompensation-free survival in PBCMORRISTOWN, N.J., June 05, 2024 (GLOBE...